Revised SPC: Kyntheum (brodalumab) 210 mg Solution for Injection

SPC has been updated to warn rare cases of anaphylactic reactions have been reported in post-marketing setting & previous warning on Crohn’s disease (CD) has been updated with statement that brodalumab is not recommended in patients with IBD (including CD and ulcerative colitis).


electronic Medicines compendium